UGalderma ubhengeze ukuba i-FDA ivume i-Restylane Defyne, i-HA dermal filler, yokwandisa isilevu.
Ubuhle kunye nenkampani yoxubo-mayeza i-Galderma isandula ukubhengeza ukuba i-FDA ivume i-Restylane Defyne yokuphucula kunye nokulungiswa kokuthotywa kwe-chin ephakathi ukuya kwephakathi kwabantu abadala abangaphezu kweminyaka engama-21 ubudala.
I-Restylane Defyne, eyavunywa okokuqala kwi-2016, i-hyaluronic acid (HA) i-dermal filler ekuqaleni yayisetyenziselwa inaliti ephakathi ukuya enzulu kwizicubu zobuso ukunyanga imibimbi yobuso kunye nokugoba okuphakathi.
I-Galderma isebenzisa inkqubo yayo ekhethekileyo yokuvelisa iteknoloji ye-XpresHAN, eyaziwa kwihlabathi jikelele njenge-Optimal Balance Technology (OBT), ukwenza i-gel ejoyiweyo ene-injection enokudibanisa lula eluswini lokuhamba kwendalo kunye nokuguquguqukayo.
"Oku kubonisa ixesha le-8 lokuba uGalderma efumene imvume yobuhle be-FDA kwiminyaka eyi-5, kwaye ibonisa ukuba sizibophezele ixesha elide ukukhuthaza i-aesthetics ngokusebenzisa izinto ezintsha," kusho u-Alisa Lask, umphathi jikelele kunye nomongameli we-Galderma's American aesthetics ishishini, wathi. kwingxelo yeendaba ebhengeza ulwamkelo.“Isilevu sisiseko sobuso kwaye sinokulungelelanisa ezinye iimpawu zakho.Abathengi ngoku banokusebenzisa iindlela ezingezizo utyando, ezikhuselekileyo zokusombulula iingxaki zesilevu.I-brand isebenzisa itekhnoloji yeXpresHAN egqwesileyo ukuyila kunye nokuvelisa iziphumo ezihlala ixesha elide. ”
Ukuvunywa kwe-Restylane Defyne kwafunyanwa emva kwedatha evela kwiSigaba se-3 solingo lwekliniki oluxhasa ukhuseleko kunye nokunyamezela kwayo ekwandiseni umhlathi.Kwizigulane ezikuphononongo, i-86% ayizange ibe naziphi na iziganeko ezimbi ezinxulumene nonyango, kunye nesiganeko esisodwa esimodareyitha sentlungu ye-injection site.
Iipesenti ezingamashumi alithoba anesithoba zezigulane zichaze ukuphuculwa kwenkangeleko ye-chin ephumayo (xa ibuzwa kwiiveki ze-12), kwaye i-96% yee-injection ithi unyango luphucule ukubonakala kwe-chin ephumayo ukuya kutsho kunyaka.
Ulingo lubonise ukuba i-74% yezigulane ibe nokuphucuka okuphawulekayo kwiprojekthi ye-chin kwithuba elifikelela kunyaka omnye, xa kuthelekiswa ne-86% kwiiveki ze-12.Oku kulinganiswa kusetyenziswa iGartner's Chin Retraction Scale (GCRS).Iziphumo zobuhle emva kokuba unyango lulungile kwaye lubonakaliswe kwinqanaba eliphezulu lokwaneliseka kwesifundo kwi-FACE-Q kunye ne-Global Aesthetic Improvement Scale (GAIS) imibuzo.
“Izigulana zam zihlala ziza kum zizobuza malunga neendlela ezintsha zonyango ezinokuthi ziqhubeke nokugcina eyona meko yazo ingcono.Abantu abaninzi bayamangaliswa xa ndichaza umphumo womhlathi owandisiweyo kunye nokulungelelaniswa kobuso obuphantsi ngundoqo wokunceda ukufezekisa umtsalane wobuso obugcweleyo, "u-Anne Chapas, MD, i-dermatologist eqinisekisiweyo yebhodi kunye ne-dermatologist eNew York, kunye nomphandi Ulingo lwezonyango lwe-Restylane Defyne Chin, utshilo kwingxelo yeendaba."Inxalenye esezantsi yobuso ihlala ihamba, ngoko kubalulekile ukuba izigulana zikhethe iifayili eziguquguqukayo ezifana ne-Restylane Defyne, eziye zaphuhliswa ngokwesayensi ukuze zihambelane nembonakalo yobuso babo."
Ixesha lokuposa: Jul-22-2021